Cargando…
Estimating the global demand curve for a leishmaniasis vaccine: A generalisable approach based on global burden of disease estimates
BACKGROUND: A pressing need exists to develop vaccines for neglected diseases, including leishmaniasis. However, the development of new vaccines is dependent on their value to two key players–vaccine developers and manufacturers who need to have confidence in the global demand in order to commit to...
Autores principales: | Mohan, Sakshi, Revill, Paul, Malvolti, Stefano, Malhame, Melissa, Sculpher, Mark, Kaye, Paul M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232160/ https://www.ncbi.nlm.nih.gov/pubmed/35696433 http://dx.doi.org/10.1371/journal.pntd.0010471 |
Ejemplares similares
-
Human leishmaniasis vaccines: Use cases, target population and potential global demand
por: Malvolti, Stefano, et al.
Publicado: (2021) -
Overcoming roadblocks in the development of vaccines for leishmaniasis
por: Kaye, Paul M., et al.
Publicado: (2021) -
A Financial and Global Demand Analysis to Inform Decisions for Funding and Clinical Development of Group B Streptococcus Vaccines for Pregnant Women
por: Malvolti, Stefano, et al.
Publicado: (2021) -
Estimating the future global dose demand for measles–rubella microarray patches
por: Ko, Melissa, et al.
Publicado: (2023) -
Bacillus Calmette-Guérin (BCG) vaccine: A global assessment of demand and supply balance
por: Cernuschi, Tania, et al.
Publicado: (2018)